Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First ...
Aclarion expands its multi-center CLUE Trial to New Jersey, led by Dr. Justin Kubeck at Ocean Pain and Spine, aiming to assess Nociscan's AI data impact on chronic low back pain treatment plans. Nociscan, Aclarion's SaaS platform, uses biomarkers and AI to identify pain sources in the lumbar spine, aiding physicians in treatment decisions.
Reference News
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First ...
Aclarion expands its multi-center CLUE Trial to New Jersey, led by Dr. Justin Kubeck at Ocean Pain and Spine, aiming to assess Nociscan's AI data impact on chronic low back pain treatment plans. Nociscan, Aclarion's SaaS platform, uses biomarkers and AI to identify pain sources in the lumbar spine, aiding physicians in treatment decisions.